Epstein-Barr Virus (EBV) infection – the infection pathogen behind so-called 'glandular fever' – is a risk factor for multiple sclerosis (MS), but the exact mechanisms involved have been ...
A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
In animal studies, a similar vaccine candidate from ModeX generated neutralising antibodies in mice, ferrets, and nonhuman primates that inhibited EBV entry into both B cells and epithelial cells ...
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...
A newly identified condition, called “post-vaccination syndrome” (PVS), appears to be linked to mRNA Covid vaccines.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, ...
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin’s lymphoma. Its symptoms can vary, making it difficult to diagnose. The outlook for people with IVLBCL is typically poor.
Some also display distinct biological markers, including unusual immune cell activity and traces ... is its potential connection to the Epstein-Barr virus (EBV), a common infection that typically ...